J. E.  Davis net worth and biography

J. Davis Biography and Net Worth

Jim Davis is Chairman, CEO and President of Quest Diagnostics. He assumed the role of CEO and President on November 1, 2022, and then took on the additional title of Chairman on April 1, 2023.

Jim joined Quest in April 2013 and initially served as Senior Vice President, Diagnostic Services. He was named Senior Vice President, Operations in February 2014 and was elected CEO and President in February 2022.

Before joining Quest, he served as CEO of InSightec, Inc., a medical device company. Prior to that, Jim held senior management positions in a two-decade career in General Electric’s aviation and healthcare businesses, including leading GE’s MRI business for five years. Before GE, Jim led the development of strategic and operating initiatives for clients of McKinsey & Company, Inc.

Jim holds a master’s degree in management from the Sloan School of Management at Massachusetts Institute of Technology, a master’s degree in science from MIT and a bachelor's degree in aeronautical engineering from the University of Michigan.

How do I contact J. E. Davis?

The corporate mailing address for Davis and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on J. E. Davis' contact information.

Has J. E. Davis been buying or selling shares of Quest Diagnostics?

J. E. Davis has not been actively trading shares of Quest Diagnostics during the last quarter. Learn More on J. E. Davis' trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes J. Davis (CEO), Mark Delaney (SVP), Michael Deppe (CAO), Catherine Doherty (SVP), Vicky Gregg (Director), Mark Guinan (CFO), Karthik Kuppusamy (SVP), Gary Pfeiffer (Director), Patrick Plewman (SVPfor Diagnostic Services), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 24 times. They sold a total of 175,734 shares worth more than $31,849,947.70. The most recent insider tranaction occured on November, 25th when CEO J. E Davis sold 55,093 shares worth more than $10,589,976.46. Insiders at Quest Diagnostics own 8.2% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 11/25/2025.

J. E. Davis Insider Trading History at Quest Diagnostics

See Full Table

J. E. Davis Buying and Selling Activity at Quest Diagnostics

This chart shows J. E Davis's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More

Today's Range

Now: $184.27
Low: $182.25
High: $185.12

50 Day Range

MA: $184.07
Low: $174.90
High: $192.41

2 Week Range

Now: $184.27
Low: $148.70
High: $197.55

Volume

1,044,858 shs

Average Volume

1,125,294 shs

Market Capitalization

$20.50 billion

P/E Ratio

21.63

Dividend Yield

1.75%

Beta

0.62